Introduction
In 1921, Peutz first reported a case of a Dutch family with multiple polyps throughout the gastrointestinal tract and mucocutaneous pigmentation. In 1949, Jeghers et al. reported 10 cases involving similar complaints and they noted a connection between multiple polyps and pigmentation. Peutz-Jeghers syndrome (PJS) is a rare, but life-threatening, familial inherited disease (1, 2) . The estimated incidence of PJS ranges from 1/50,000 to 1/200,000. PJS can significantly increase the risk of malignancies, and especially gastrointestinal malignancies (3) . Reported here are 4 cases of PJS in one family.
Case report
On April 2015, a 22-year-old male was admitted to this department for intermittent abdominal discomfort and diarrhea. The young man had scattered black spots on his lips and fingers. Eight years ago, he was diagnosed with intestinal obstruction due to multiple polyps in his small intestine and he underwent intestinal resection at a local hospital. PJS was diagnosed. Computed tomography scans of the abdomen ( Figure 1 ) and colonic endoscopy and upper gastrointestinal endoscopy ( Figure 2 ) at admission to this Department revealed a number of large polyps. The maximum length of polyps in the transverse colon was 12 cm. Subsequently, the patient underwent endoscopic polypectomy. Histology confirmed the presence of inflammatory polyps ( Figure  3 ). The patient was discharged without problem.
On June 2015, his cousin, a 19-year-old girl, was also admitted to this Department for colonic endoscopy. The girl had slight mucocutaneous pigmentation on her lips and fingers. She was diagnosed with PJS by a local hospital and intussusception was noted, so she underwent intestinal resection in 2012. Histology confirmed the presence of hamartomatous polyps. Upon admission, the polyps were treated via a doubleballoon endoscopic polypectomy. The patient refused to undergo subsequent histological examinations, and she was discharged without problem.
After a detailed survey of 14 members of the original patient's family, his father and uncle were also diagnosed with PJS. His father died of a post-operative infection at the age of 30. His uncle died of lung adenocarcinoma at the age of 44. His cousin was alive and age 19. Other family members had no symptoms or signs of PJS ( Figure  4 ). The original patient and his cousin are being followed with regular endoscopic examinations.
Discussion
PJS is an autosomal dominant disease with no significant difference in the gender or race of individuals it affects. Patients with PJS have different complications such as obstruction, intussusception, and anemia (4). those complications. Laser therapy can be used to treat pigmentation if the patient so desires. Double-balloon endoscopy allows both examination and treatment of polyps. A timely polypectomy with double-balloon endoscopy can reduce the need for abdominal surgery and consequent problems in patients with PJS (5). The WHO diagnostic criteria for PJS include: i) ≥3 hamartomatous polyps; ii) hamartomatous polyps and a family history of PJS; iii) mucocutaneous pigmentation and a family history of PJS; or iv) mucocutaneous pigmentation and hamartomatous polyps (6) . Hamartomatous polyps were considered to be benign lesions, but there is uncertainty as to whether or not PJS-associated hamartomas were pre-malignant in PJS.
Some researchers believe that PJS is an epiphenomenon preceding a cancer-prone state (7, 8) . In contrast, some researchers hypothesize that PJS polyps follow the hamartoma-carcinoma sequence, leading to a high risk of malignancy (3, 7) . Three of the family members studied here had hamartoma polyps that were confirmed histologically, but one only had inflammatory polyps. One family member had hamartomatous polyps that were confirmed histologically and eventually died of lung adenocarcinoma. Inflammatory polyps, hamartomatous polyps, and lung adenocarcinoma were found in one family. Thus, PJS polyps may follow the hamartomacarcinoma sequence. A further follow-up study of this family is needed to prove this hypothesis.
Further screening for the STK11/LKB1 gene mutation should help to evaluate the risk of malignant transformation in two young survivors (9) . However, both patients refused genetic testing. Clearly, a close follow-up with physical examinations and endoscopy is recommended. 
